Researchers call for stronger financing to tackle Antimicrobial Resistance

Medical researchers have warned about a growing issue with Antimicrobial Resistance (AMR) affecting humans, animals and the environment. In 2021, there were 6,670 deaths directly attributed to AMR, and 28,500 related deaths. Researchers are now calling for a collaborative, multi-sectoral strategy to improve governance and financing to combat this growing threat, likening it to a "ticking time bomb."

AMR occurs when disease-causing pathogens adapt and become less responsive to treatments, making it increasingly difficult to treat infections. While resistance develops naturally, its spread has been accelerated by the misuse and overuse of antimicrobials in healthcare, agriculture, and animal production. Factors such as poor sanitation, weak surveillance systems, inadequate resources, and climate change have exacerbated the problem.

In Kenya, the Ministry of Health, along with the Kenya National Public Health Institute (KNPHI) and Kenya Medical Research Institute (KEMRI), is hosting a summit in Mombasa to identify effective strategies for AMR containment. The summit will bring together policymakers, researchers, and stakeholders to explore practical measures for strengthening governance and financing.

Dr. Emmanuel Tanui, KNPHI's National AMR Focal Point, emphasized that Kenya is advancing in this fight through the development of a National Action Plan on AMR prevention and containment for 2023-2027. The plan aims to strengthen governance, enhance surveillance and research, and promote sustainable financing. However, Dr. Martin Bundi from KEMRI warns that failing to address AMR could lead to economic losses of 3.8% of global GDP and push 24 million people into poverty, with low- and middle-income countries bearing the brunt of the impact.

Addressing AMR requires collaboration across various sectors, including human health, agriculture, the environment, and wildlife, as well as improved waste management and antibiotic disposal practices.